+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Cardioverter Defibrillators (ICD) (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 75 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5459968
Implantable Cardioverter Defibrillators (ICD) (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Implantable Cardioverter Defibrillators (ICD) (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Implantable Cardioverter Defibrillators (ICD) Overview
3 Products under Development
3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies
4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview
5.1 Advanced BioInformatics GmbH Company Overview
5.1.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 AIS Inc. Company Overview
5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Arrhythmia Dynamics LLC Company Overview
5.3.1 Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Boston Scientific Corp Company Overview
5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 CardiaLen, Inc. Company Overview
5.5.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Coridea, LLC Company Overview
5.6.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 InnerPulse Inc (Inactive) Company Overview
5.7.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Johns Hopkins University Company Overview
5.8.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.9 Kenergy Inc. Company Overview
5.9.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Massachusetts General Hospital Company Overview
5.10.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.11 Max Planck Institute for Dynamics and Self-Organization Company Overview
5.11.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
5.12 Medicool Technologies Inc Company Overview
5.12.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Medtronic Inc Company Overview
5.13.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Medtronic Plc Company Overview
5.14.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.15 MicroPort CRM SA Company Overview
5.15.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview
5.16 MicroPort Scientific Corp Company Overview
5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 Smartwave Medical Ltd (Inactive) Company Overview
5.17.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.18 Suzhou Wushuang Medical Equipment Co Ltd Company Overview
5.18.1 Suzhou Wushuang Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Chicago Company Overview
5.19.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments
6.1 Sep 14, 2021: Nihon Kohden announces a revision to its forecast for financial results for the first half of the fiscal year ending March 31, 2022
6.2 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.3 Aug 09, 2021: American Medical Association issues new category III CPT code for ZOLL Medical’s TherOx SSO2 therapy
6.4 Aug 04, 2021: Nihon Kohden Announces a Revision to its Forecast for Financial Results
6.5 Aug 04, 2021: Nihon Kohden Announces Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2022
6.6 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results
6.7 Jul 30, 2021: Fukuda Denshi Co. Announces Financial Results for the First Quarter of the Fiscal Year Ending March 2022
6.8 Jul 30, 2021: Fukuda Denshi Notice Regarding Business Forecast and Dividend Forecast for the Fiscal Year Ending March 2022
6.9 Jul 28, 2021: CONMED Announces financial results for the second quarter ended June 30, 2021
6.10 Jul 21, 2021: Increased physical activity after ICD implantation linked to less hospitalization, death
6.11 Jul 14, 2021: Nihon Kohden Announces its Consolidated Financial Forecast for the First Quarter of Fiscal 2021
6.12 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders
6.13 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.14 May 14, 2021: Fukuda Denshi announces Financial Results for the Fiscal Year Ending March 2021
6.15 May 13, 2021: Nihon Kohden announces FY2020 consolidated financial results
6.16 Apr 28, 2021: Nihon Kohden Announces Change in Directors
6.17 Apr 28, 2021: Fukuda Denshi announces full year consolidated earnings forecast for fiscal year ending march 2021
6.18 Apr 28, 2021: CONMED Announces First Quarter Financial Results
6.19 Apr 20, 2021: Biotronik: Experts Make the Case for Improved Patient Care in Single-Chamber ICD and CRT-D Therapy with Pioneering DX Technology
6.20 Apr 15, 2021: Nihon Kohden Announces a Revision to its Forecast for Financial Results
6.21 Apr 01, 2021: CONMED to Announce First Quarter 2021 Financial Results on April 28, 2021
6.22 Mar 26, 2021: Philips' Announces Second-Quarter Results 2021
6.23 Mar 23, 2021: CONMED Announces Annual Meeting of Stockholders
6.24 Mar 22, 2021: Philips convenes the 2021 Annual General Meeting of Shareholders
6.25 Feb 23, 2021: Philips publishes its Annual Report 2020
6.26 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.27 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.28 Feb 16, 2021: CONMED Corporation to Participate in a Virtual Fireside Chat at the SVB Leerink Global Healthcare Conference
6.29 Feb 13, 2021: Shree Pacetronix announces Submission of Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report For The Quarter And Nine Months Ended 31St December, 2020
6.30 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.31 Feb 03, 2021: Nihon Kohden provides Consolidated Financial Highlights for the Third Quarter of FY2020 (From April 1, 2020 to December 31, 2020)
6.32 Jan 29, 2021: Fukuda Denshi Provides Summary Report on Financial Results for the Third Quarter of the Year Ending March 31st, 2021
6.33 Nov 06, 2020: Philips presents its performance and value creation trajectory for the 2021-2025 period at its Capital Markets Day
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
  • Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
  • Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiac Rhythm Management Device - Product Status
  • Cardiac Rhythm Management Device - Product Description
  • AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Guardian - Product Status
  • Guardian - Product Description
  • Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • IntelliSync ICD Control Algorithm - Product Status
  • IntelliSync ICD Control Algorithm - Product Description
  • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • S-ICD System 1.5 - Product Status
  • S-ICD System 1.5 - Product Description
  • S-ICD System 2.0 - Product Status
  • S-ICD System 2.0 - Product Description
  • VITALITY NXT Defibrillator - Product Status
  • VITALITY NXT Defibrillator - Product Description
  • CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • MultiPulse Therapy Device - Product Status
  • MultiPulse Therapy Device - Product Description
  • CardiaLen, Inc. - Ongoing Clinical Trials Overview
  • MultiPulse Therapy Device - A Clinical Feasibility Study to Evaluate Patient Perception of MPT
  • MultiPulse Therapy Device - A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-energy Therapy in Patients with Atrial Fibrillation (US)
  • MultiPulse Therapy Device - A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-energy Therapy in Patients with Atrial Fibrillation Energy Therapy in Patients with Atrial Fibrillation
  • MultiPulse Therapy Device - Study Evaluating the Safety and Efficacy of MultiPulse Therapy in an Acute Clinical Setting
  • Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table-Top PaDe System - Product Status
  • Table-Top PaDe System - Product Description
  • InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • PICD - Product Status
  • PICD - Product Description
  • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiac Sock Electrode And Implantable Defibrillator System - Product Status
  • Cardiac Sock Electrode And Implantable Defibrillator System - Product Description
  • Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Unconditional MRI Compatible Implantable Defibrillator - Product Status
  • Unconditional MRI Compatible Implantable Defibrillator - Product Description
  • Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Status
  • Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Description
  • Vagal Stimulation ICD Device - Product Status
  • Vagal Stimulation ICD Device - Product Description
  • Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
  • Implantable Defibrillator - Product Status
  • Implantable Defibrillator - Product Description
  • Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Implantable Defibrillator - Product Status
  • Implantable Defibrillator - Product Description
  • Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
  • LUMINA EV-ICD - Product Status
  • LUMINA EV-ICD - Product Description
  • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Aurora EV-ICD Extravascular Defibrillation System - Product Status
  • Aurora EV-ICD Extravascular Defibrillation System - Product Description
  • Chronicle ICD - Product Status
  • Chronicle ICD - Product Description
  • Medtronic Plc - Ongoing Clinical Trials Overview
  • Aurora EV-ICD Extravascular Defibrillation System - Extravascular ICD Pilot Study
  • Aurora EV-ICD Extravascular Defibrillation System - Extravascular ICD Pivotal Study: EV ICD
  • MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview
  • Navigo 4LV 2D - Product Status
  • Navigo 4LV 2D - Product Description
  • Navigo 4LV ARC - Product Status
  • Navigo 4LV ARC - Product Description
  • Navigo 4LV PILOT - Product Status
  • Navigo 4LV PILOT - Product Description
  • Platinium ICD - Product Status
  • Platinium ICD - Product Description
  • Subcutaneous ICD - Product Status
  • Subcutaneous ICD - Product Description
  • MicroPort CRM SA - Ongoing Clinical Trials Overview
  • Navigo 4LV 2D - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
  • Navigo 4LV ARC - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
  • Navigo 4LV PILOT - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
  • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Gali MRI ICD - Product Status
  • Gali MRI ICD - Product Description
  • Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Fully Automatic Implantable Atrial Defibrillator - Product Status
  • Fully Automatic Implantable Atrial Defibrillator - Product Description
  • Suzhou Wushuang Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Implantable Cardioverter Defibrillator - Product Status
  • Implantable Cardioverter Defibrillator - Product Description
  • University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • Implantable Cardioverter Defibrillator - Product Status
  • Implantable Cardioverter Defibrillator - Product Description
  • Glossary

List of Figures
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
  • Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
  • Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advanced BioInformatics GmbH
  • AIS Inc.
  • Arrhythmia Dynamics LLC
  • Boston Scientific Corp
  • CardiaLen, Inc.
  • Coridea, LLC
  • InnerPulse Inc (Inactive)
  • Johns Hopkins University
  • Kenergy Inc.
  • Massachusetts General Hospital
  • Max Planck Institute for Dynamics and Self-Organization
  • Medicool Technologies Inc
  • Medtronic Inc
  • Medtronic Plc
  • MicroPort CRM SA
  • MicroPort Scientific Corp
  • Smartwave Medical Ltd (Inactive)
  • Suzhou Wushuang Medical Equipment Co Ltd
  • University of Chicago